Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell L Shiffman

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Gastroenterology & Hepatology|January 19, 2013
The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patientsTarek Hassanein, Mitchell L Shiffman, Nizar N Zein
Antiviral Therapy|May 12, 2009
Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological responseStefan Zeuzem, Mario Rizzetto, Peter Ferenci, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2003
Controversies in the management of hepatitis C virus infection after liver transplantationMitchell L Shiffman, Hugo E Vargas, Gregory T Everson
The American Journal of Gastroenterology|November 15, 2017
The Cochrane Review Conclusion for Hepatitis C DAA Therapies is WrongPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
The American Journal of Gastroenterology|June 20, 2018
Response to Perrella et alPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
Mayo Clinic Proceedings|May 29, 2014
My treatment approach to chronic hepatitis C virusMitchell L Shiffman, April G Long, Amy James, et al.
Medicine|October 6, 2023
Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedureSanjaya K Satapathy, Vinay Sundaram, Mitchell L Shiffman, et al.
The American Journal of Gastroenterology|July 29, 2015
Treatment of chronic HCV with sofosbuvir and simeprevir in patients with cirrhosis and contraindications to interferon and/or ribavirinMitchell L Shiffman, Amy M James, April G Long, et al.
Journal of Hepatology|December 15, 2010
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infectionMichael W Fried, Stephanos J Hadziyannis, Mitchell L Shiffman, et al.
Digestive Diseases and Sciences|June 12, 2009
Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosisErik Seth Kramer, Charlotte Hofmann, Paula G Smith, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Gastroenterology & Hepatology|January 19, 2013
The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patientsTarek Hassanein, Mitchell L Shiffman, Nizar N Zein
Antiviral Therapy|May 12, 2009
Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological responseStefan Zeuzem, Mario Rizzetto, Peter Ferenci, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2003
Controversies in the management of hepatitis C virus infection after liver transplantationMitchell L Shiffman, Hugo E Vargas, Gregory T Everson
The American Journal of Gastroenterology|November 15, 2017
The Cochrane Review Conclusion for Hepatitis C DAA Therapies is WrongPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
The American Journal of Gastroenterology|June 20, 2018
Response to Perrella et alPaul Y Kwo, Mitchell L Shiffman, David E Bernstein
Mayo Clinic Proceedings|May 29, 2014
My treatment approach to chronic hepatitis C virusMitchell L Shiffman, April G Long, Amy James, et al.
Medicine|October 6, 2023
Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedureSanjaya K Satapathy, Vinay Sundaram, Mitchell L Shiffman, et al.
The American Journal of Gastroenterology|July 29, 2015
Treatment of chronic HCV with sofosbuvir and simeprevir in patients with cirrhosis and contraindications to interferon and/or ribavirinMitchell L Shiffman, Amy M James, April G Long, et al.
Journal of Hepatology|December 15, 2010
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infectionMichael W Fried, Stephanos J Hadziyannis, Mitchell L Shiffman, et al.
Digestive Diseases and Sciences|June 12, 2009
Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosisErik Seth Kramer, Charlotte Hofmann, Paula G Smith, et al.
Pageof 21